Ribostamicin je aminoglikozidni antibiotik.
Ribostamicin
|
| (IUPAC) ime
|
| (1R,2R,3S,4R,6S)-4,6-diamino-3-hidroksi-2-(β-D-ribofuranoziloksi)cikloheksil 2,6-diamino-2,6-dideoksi-α-D-glukopiranozid
|
| Klinički podaci
|
| AHFS/Drugs.com
|
Internacionalno ime leka
|
| Identifikatori
|
| CAS broj
|
53797-35-6
|
| ATC kod
|
J01GB10
|
| PubChem[1][2]
|
5066
|
| UNII
|
2Q5JOU7T53  Y
|
| ChEMBL[3]
|
CHEMBL1256830 Y
|
| Hemijski podaci
|
| Formula
|
C17H34N4O10
|
| Mol. masa
|
454,47266 g/mol
|
| SMILES
|
eMolekuli & PubHem
|
| InChI |
|---|
InChI=1S/C17H34N4O10/c18-2-6-10(24)12(26)8(21)16(28-6)30-14-5(20)1-4(19)9(23)15(14)31-17-13(27)11(25)7(3-22)29-17/h4-17,22-27H,1-3,18-21H2 Y
Key: NSKGQURZWSPSBC-UHFFFAOYSA-N Y |
|
| Sinonimi
|
(2R,3S,4R,5R,6R)-5-amino-2-(aminometil)-6[(1R,2R,3S,4R,6S)-4,6-diamino-2[(2S,3R,4S,5R)-3,4-dihidroksi-5-(hidroksimetil)oksolan-2-il]oksi3-hidroksicikloheksil]oksi}oksan-3,4-diol
|
| Farmakoinformacioni podaci
|
| Trudnoća
|
?
|
| Pravni status
|
|
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Literatura
uredi
Spoljašnje veze
uredi
